MedMira Inc
XTSX:MIR

Watchlist Manager
MedMira Inc Logo
MedMira Inc
XTSX:MIR
Watchlist
Price: 0.065 CAD Market Closed
Market Cap: 49.3m CAD

MedMira Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

MedMira Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
MedMira Inc
XTSX:MIR
EPS (Diluted)
CA$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
0%
Titan Medical Inc
TSX:TMD
EPS (Diluted)
$0
CAGR 3-Years
53%
CAGR 5-Years
54%
CAGR 10-Years
37%
Profound Medical Corp
TSX:PRN
EPS (Diluted)
-$1
CAGR 3-Years
3%
CAGR 5-Years
-6%
CAGR 10-Years
9%
Theralase Technologies Inc
XTSX:TLT
EPS (Diluted)
CA$0
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
9%
O
Ondine Biomedical Inc
LSE:OBI
EPS (Diluted)
CA$0
CAGR 3-Years
52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Conavi Medical Corp
XTSX:CNVI
EPS (Diluted)
$0
CAGR 3-Years
-11%
CAGR 5-Years
-63%
CAGR 10-Years
28%
No Stocks Found

MedMira Inc
Glance View

Market Cap
45.6m CAD
Industry
Health Care

MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm is engaged in the development and commercialization of rapid diagnostics and technology platforms. The MedMira Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its technology platform detects multiple biomarkers specific to several diseases using a single cartridge. Its Multiplo line of rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis uses the platforms capabilities to deliver approximately up to four test results using one test cartridge and one drop of specimen. The company also has a research product line that facilitates technology licensing, contract manufacturing, and regulatory consulting. The firm sells its rapid tests through a network of medical distributors and strategic business development partners to customers in all sectors of the healthcare industry, including laboratories, hospitals and point-of-care clinics, among others.

MIR Intrinsic Value
0.001 CAD
Overvaluation 98%
Intrinsic Value
Price

See Also

What is MedMira Inc's EPS (Diluted)?
EPS (Diluted)
-0 CAD

Based on the financial report for Jul 31, 2025, MedMira Inc's EPS (Diluted) amounts to -0 CAD.

What is MedMira Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
0%

Back to Top